VOLUME 16 NUMBER 12 dEcEMBER 2009 nature structural & molecular biology a r t i c l e s c-di-GMP is a second messenger widespread in bacteria, where it regulates complex physiological processes associated with transition between motile-planktonic and sedentary-adhesive lifestyles and influences phenomena such as the formation of biofilms, the expression of virulence genes and the persistence of infections (reviewed in refs. 1-4). Diguanylate cyclases (DGCs), characterized by a GGDEF domain, synthesize c-di-GMP from two GTP molecules, and c-di-GMP is degraded by phosphodiesterases (PDEs) with EAL and HD-GYP domains in response to various signals. Whole-genome sequencing demonstrates the ubiquity of proteins with these signatures in bacteria, where they are often found in large numbers in the genome of one organism. However, despite the ubiquity of DGCs and PDEs, only four types of effector proteins are known-the PilZ family of proteins, the FleQ transcription factor, PelD and the I-site effectors. Thus, the mechanisms by which global changes in gene expression are modulated by c-di-GMP are a subject of intense research [1] [2] [3] [4] .
a r t i c l e s c-di-GMP is a second messenger widespread in bacteria, where it regulates complex physiological processes associated with transition between motile-planktonic and sedentary-adhesive lifestyles and influences phenomena such as the formation of biofilms, the expression of virulence genes and the persistence of infections (reviewed in refs. [1] [2] [3] [4] . Diguanylate cyclases (DGCs), characterized by a GGDEF domain, synthesize c-di-GMP from two GTP molecules, and c-di-GMP is degraded by phosphodiesterases (PDEs) with EAL and HD-GYP domains in response to various signals. Whole-genome sequencing demonstrates the ubiquity of proteins with these signatures in bacteria, where they are often found in large numbers in the genome of one organism. However, despite the ubiquity of DGCs and PDEs, only four types of effector proteins are known-the PilZ family of proteins, the FleQ transcription factor, PelD and the I-site effectors. Thus, the mechanisms by which global changes in gene expression are modulated by c-di-GMP are a subject of intense research [1] [2] [3] [4] .
Computational searches delineated a bacterial RNA motif widely associated with genes related to the environment, membranes and motility (GEMM) 5 . The diversity of genes associated with the GEMM motif is much broader than is typical of riboswitches, which generally only regulate a limited set of genes responsible for the biosynthesis, transport or degradation of their cognate metabolites. Therefore, it was hypothesized that the GEMM motif may respond to an intracellular signaling molecule 5 . Recently, it was discovered that the GEMM motif specifically binds c-di-GMP and serves a direct role in the regulation of gene expression 6 , confirming predictions of the existence of such a riboswitch 1, 2 . The c-di-GMP riboswitch is the first known example of a gene-regulatory RNA that recognizes a second messenger. It binds c-di-GMP with high specificity and K d ~1 nM. This affinity is ~1,000 times tighter than that for the second messenger of an Escherichia coli PilZ c-di-GMP binding protein 6 and is comparable to the tightest RNA-small molecule interactions known 7 . The broad distribution among bacteria of this RNA domain 6 , the physiological importance of c-di-GMP, and its involvement in controlling virulence of many pathogens make this riboswitch an important target for structure-function studies.
To provide a framework with which to understand how this RNA recognizes the bacterial second messenger, we have determined the cocrystal structure of a canonical c-di-GMP riboswitch from V. cholerae. The structure and previous biochemical characterization suggest that this riboswitch undergoes a conformational change upon ligand binding. We analyzed the solution behavior of the riboswitch through a combination of small-angle X-ray scattering (SAXS) and enzymatic probing. These studies indicate that allosteric binding of c-di-GMP modulates the global architecture of the RNA, which switches between markedly different free and c-di-GMP-bound conformations.
RESULTS

Crystal structure determination
Previous analyses of the V. cholerae tfoX c-di-GMP riboswitch 6 delineated the minimal 5′ and 3′ RNA boundaries (the 'aptamer domain') needed for tight binding (K d ≤ 10 nM) to the second messenger. A phylogenetically conserved helix (paired region P2) is closed by a loop (L2) that is highly variable 5 . Our crystallization construct encompasses these boundaries and incorporates 8 a binding site for the spliceosomal protein U1A in place of L2. Consistent with lack of conservation of L2, this construct binds both c-di-GMP and the U1A RNA-binding domain (RBD) (Supplementary Fig. 1 ).
a r t i c l e s
We solved the structure de novo by molecular replacement using the U1A-RBD cognate complex 9 and short A-form duplexes of arbitrary sequence as search models, analogous to what has been reported for two ribozymes 10, 11 and an unrelated riboswitch 12 . This procedure 13 unambiguously revealed the bound c-di-GMP in residual electron density maps phased with models that had never included the second messenger (Fig. 1a) , and it allowed complete tracing of both RNA molecules in the asymmetric unit (Fig. 1b) . The crystallographic model (R free = 29.2% at 3.2 Å resolution) has a mean coordinate precision of 0.5 Å (Online Methods and Table 1 ).
Overall ligand-bound structure
The c-di-GMP riboswitch is h-shaped (Fig. 1c,d ). In addition to the two predicted helices (hereafter, P1b and P2), a third helix, P1a, is formed by the 5′-and 3′-most nucleotides of the aptamer domain, which were thought 5, 6 to be single stranded. The c-di-GMP binding site is formed by nucleotides that join the three helical segments (J1a/b, J1b/2 and J2/1a). One of the guanine bases of the bound c-di-GMP (hereafter, g I ) stacks on the uppermost base pair of P1a, while the other (g II ) stacks underneath the bottom base pair of P1b. The two nucleobases of the second messenger sandwich that of A47 from J1b/2, thus maintaining continuous base stacking between P1a and P1b. As predicted by phylogenetic analysis, P1b is capped by a GAAA tetraloop that makes canonical interactions (mediated by a ribose zipper and stacking of the base of A33 under that of A62) with a tetraloop receptor in P2 (refs. 5,6) .
A second interhelical interaction mediating side-by-side packing of P1b and P2 is a cis-Watson-Crick pair between C44 (from P1b) and G83 (extruded from P2). Both nucleotides adopt the anti conformation, unlike in the hairpin ribozyme 14, 15 where the syn conformation of the guanosine in the interhelical Watson-Crick pair enforces a closer approach of the two helices. The extrusion of G83 is accomplished by an S-shaped turn of the backbone, constructed by juxtaposition of the G57•U81 wobble pair and two base triples, that results in marked underwinding of P2 (Supplementary Fig. 2a ). C44 projects into the minor groove of the overwound P1b. Overwinding results from cross-strand stacking of A24 on C44 and A43 on A23 and from formation of a sheared pair between A25 and G42 ( Supplementary  Fig. 2b ). In addition to these nonstandard conformations of P1b and P2, the interhelical C44-G83 base pair appears to be stabilized by stacking of G83 on A49 (from J1b/2). Consistent with the importance of this interhelical base pair, nucleotides corresponding to C44 and G83 are conserved in at least 97% of the 503 c-di-GMP riboswitches discovered by Sudarsan et al. 6 in diverse bacterial genomes. Similarly, nucleotides whose interactions result in overwinding of P1b (corresponding to A23, A24 and A25) and underwinding of P2 (corresponding to U81 and A82) are 75-97% conserved 6 .
Second messenger recognition
J1b/2 contributes to forming the c-di-GMP-binding site and to organizing the global architecture of the riboswitch. Nucleotides corresponding to A47, A48 and A49 are at least 97% conserved across all known c-di-GMP riboswitches and are typically (>75%) followed by a guanine 6 . J1b/2 alternates between the P1a/b and the P2 stacks, thereby joining them (Figs. 1d and 2a) . Whereas A47 together with the bound c-di-GMP forms part of the continuous stack between P1a a r t i c l e s and P1b, A48 forms part of the P2 stack by pairing with U90 through its Hoogsteen edge ( Supplementary Fig. 3 ). The next residue of J1b/2, A49, flips back into P1b, stacking underneath the interhelical C44-G83 pair. Finally, G50 pairs with U89 and forms part of the P2 stack.
Binding to the riboswitch buries 69% of the solvent-accessible surface area of the c-di-GMP molecule. The guanine bases of the second messenger face the same direction ( Supplementary Fig. 4 ) and are deeply buried, whereas the 12-member ribose phosphate ring of c-di-GMP is partially exposed in the broad major groove and is flanked on one side by nucleotides of J1a/b (Figs. 1d and 2b) . At the present resolution, cations and water molecules that may mediate additional contacts between the RNA and the ribose and phosphate moieties of c-di-GMP are unresolved. The g I nucleobase of the c-di-GMP makes a Watson-Crick base pair with the highly conserved 6 C92 of J2/1a (Fig. 2c) , and is also recognized through its sugar-edge face by A18. The latter nucleotide is not highly conserved, suggesting that this interaction varies among different c-di-GMP riboswitches. The Watson-Crick face of G20 recognizes the Hoogsteen edge of g II , which is upside down relative to g I . Across all known c-di-GMP riboswitches, either a guanosine or an adenosine residue is present at the position corresponding to G20 of this riboswitch 6 , indicating that the specific interactions used to recognize g II are somewhat variable.
Ligand binding-induced global conformational change
In-line probing analysis of the V. cholerae tfoX riboswitch 6 revealed reduction in self-scission of nucleotides 13-20, 47 and 93-96 upon c-di-GMP binding. Our structure shows that residues 13-20 and 93-96 assemble into P1a and J1a/b in the second messenger-bound form of the RNA, and that residue 47 intercalates between the two nucleobases of c-di-GMP. Together, these results suggest that the riboswitch undergoes folding induced by c-di-GMP binding. However, it is not clear whether the metabolite-induced folding is localized to the binding pocket or if the RNA undergoes a global rearrangement upon binding c-di-GMP. We tested the nature of the structural response elicited by c-di-GMP using SAXS.
Guinier analysis 16 revealed that the radius of gyration (R g ) of the c-di-GMP riboswitch aptamer compacts in response to both c-di-GMP and Mg 2+ (Supplementary Table 1) .
At a Mg 2+ concentration of 0.5 mM (below the physiologic level), the R g (~32 Å) is insensitive to saturating c-di-GMP. However, in the presence of physiologic (2.5 mM) Mg 2+ , the free RNA compacts (R g = 28.5 Å) and undergoes a further c-di-GMP-dependent compaction (R g = 23.9 Å). This latter R g is the same, within experimental precision, as that calculated with a model of the riboswitch based on our crystal structure (with a wild type-length L2 modeled in; Supplementary Table 2 and Supplementary Fig. 5 ). At highly stabilizing Mg 2+ (10 mM), the RNA compacts even in the absence of c-di-GMP to an R g that is comparable to that of its c-di-GMP-bound form at physiologic Mg 2+ (Supplementary Table 1) . However, Kratky analysis 16 (Fig. 3a) showed that even at 10 mM Mg 2+ , the free RNA shows behavior at high q indicative of local disorder, suggesting that the c-di-GMP-binding pocket and/or P1a remain unfolded in the absence of ligand (q is the momentum transfer and is defined as q = 4π sin(θ)/λ, where λ is the X-ray wavelength and the scattering angle is 2θ). P(r) analysis 16 (Fig. 3b) revealed a marked ligand-induced compaction of the RNA at physiologic Mg 2+ , and also a modest c-di-GMP-induced conformational change at 10 mM Mg 2+ , likely indicative of folding of the second messenger-binding pocket.
To gain further insight into the nature of the c-di-GMP-induced conformational change, we calculated low-resolution molecular envelopes 16 using SAXS data collected at physiologic Mg 2+ concentration. Reconstructions based on SAXS data from the ligand-bound state using a range of starting maximum molecular dimension (D max ) values robustly converged into an envelope with high shape complementarity (correlation coefficient = 0.94) to our cocrystal structure (with the U1A binding site replaced by a model of length identical to that of Reconstructions based on the SAXS data from the ligandfree state converged on a more elongated molecular envelope (D max ~100 Å) with two prominent arms ( Fig. 4b and Supplementary  Fig. 6c,d) . The shape of this envelope is distinctly different from that of the c-di-GMP-bound state. In addition to obvious limitations due to its low resolution, interpretation of this envelope has the caveat that the ligand-free form of the RNA might explore multiple conformations in solution. However, we found that reconstructions based on ligand-free SAXS data do converge to molecular envelopes that are self-consistent at each of the three Mg 2+ concentrations analyzed. Moreover, the variability of the reconstructions for any one of the three ligandfree conditions is comparable to that of the reconstructions from the ligand-bound SAXS data (Supplementary Fig. 7) . We conclude that building molecular models to fit the SAXS-based molecular envelope reconstruction of the ligand-free riboswitch is justified, keeping in mind that the level of detail implied by such models is limited to the approximate location and orientation of helices. In-line probing of the ligand-free riboswitch suggested that P1a is destabilized in the absence of c-di-GMP 6 . A molecular model of the free state based on our cocrystal structure in which the two strands of P1a have simply been separated, however, fails to recapitulate the experimentally determined change in R g between the free and c-di-GMP-bound states (∆R g of melted P1a model = 2.2 Å; experimental ∆R g = 4.6 Å) and fits the SAXS envelope poorly (Supplementary Table 2 and Supplementary Fig. 8 ). We noted that the dimensions of P2 fit the long arm of the free-state SAXS-based envelope, and the dimensions of P1b are a good fit for the short arm of this envelope (Fig. 4b, and Supplementary Fig. 6c,d) . A model of the c-di-GMP-free state constructed by manually rotating P1b by ~180° with the center of rotation at A47 (Fig. 4b) has a calculated ∆R g = 4.7 Å (Supplementary Table 2 ) and a correlation coefficient with the envelope of 0.91. Moreover, the scattering profile calculated from this model closely approximates the experimental scattering data, except at high q (Supplementary Fig. 9 ). Therefore, we assign the two arms of the ligand-free SAXS reconstruction to helices P1b and P2, while emphasizing that this model cannot capture molecular details (as underscored by the poor high-q fit).
Our tentative model of the ligand-free form of the RNA implies that in addition to unfolding of the c-di-GMP binding pocket (and possibly P1a), the interhelical interactions mediating side-by-side packing of P1b and P2 in the c-di-GMP-bound state are broken in the ligand-free state. To test this, we subjected the riboswitch to nuclease probing. Protection from nucleases T1 and V1 is indicative of structure formation 17, 18 . Steric clash between nucleases and a structured substrate RNA can also protect RNA segments that would otherwise be readily cleaved [19] [20] [21] [22] [23] . For instance, in two separate studies of RNase P, it was found that relative protection from nuclease V1 was consistent with occlusion of nucleotides due to tertiary structure 17 or protein binding 24 . RNase V1 probing of the c-di-GMP riboswitch revealed protection patterns that suggest occlusion due to structure formation. Specifically, nucleotides in the c-di-GMP binding pocket and three nucleotides found at the interhelical interface (A37, A48, C59) became protected from cleavage by nuclease V1 upon addition of c-di-GMP (Fig. 4c,d and Supplementary Fig. 10 ). In addition, we found protection of guanosine residues of the riboswitch from RNase T1 in the presence of c-di-GMP, consistent with stabilization of P1a, J1a/b and interhelical regions of the RNA. Noteworthy are c-di-GMP-induced RNase T1 protections of G32 (of the tetraloop) and G83 (of the interhelical G83-C44 base pair). These nucleotides are likely protected by their participation in P1b-P2 interactions. Our nuclease probing results are therefore consistent with compaction of the riboswitch induced by c-di-GMP binding, and with a free-state structure that lacks the side-by-side packing of P1b and P2 of the bound state.
DISCUSSION
The ligand-bound structures of the purine 25, 26 and c-di-GMP riboswitches show some general resemblance to each other: both RNAs are comprised of two helical stacks that pack side by side, their ligand-binding pockets are both at a three-helix junction, and in both cases the bound small molecule continues the helical stack between two of the three helices. Consistent with the dissimilarity between a free purine and c-di-GMP, the nature of the binding pockets Fig. 10 for complete autoradiogram; this panel shows the lanes corresponding to 3.0 mM Mg 2+ .) + and − denote conditions with 70 µM and 0 µM c-di-GMP, respectively. NR and BH denote no reaction and base hydrolysis. The numbers between the two gel images correspond to the sequence numbering scheme in c and indicate regions of protection from the nucleases due to the c-di-GMP induced stabilization of P1b and P2 in a side-by-side orientation. 
The long-range interactions that hold their respective two helical stacks in side-by-side arrangements are distinctly different as well, suggesting independent evolutionary origins for these two riboswitch classes.
Although the c-di-GMP riboswitch uses separate binding pockets to recognize the two nucleobases of the second messenger, the presence of both, in cyclically linked form, is required for high-affinity binding (ref. 6 and Supplementary Fig. 11a ). Our structure predicts that this riboswitch should discriminate against c-di-AMP, a recently discovered putative second messenger of archaea and bacteria 27 . If bound in an equivalent manner, the nucleobase of c-di-AMP corresponding to g I would be forced to make unfavorable hydrogen bonds with the highly conserved C92, and the other nucleobase would not be able to make the interactions with G20 and A49 in which g II engages (Fig. 2c) . This is borne out by electrophoretic mobility shift analysis, in which the riboswitch does not bind c-di-AMP even at a ligand concentration of 70 µM (Supplementary Fig. 11b ). Because bacteria use both c-di-GMP and c-di-AMP, it is possible that paralogs of the V. cholerae tfoX riboswitch might exist that recognize c-di-AMP or that do not discriminate between the two second messengers, allowing for cross-talk between pathways. The purine riboswitches are selective for either adenine or guanine, and their selectivity derives almost exclusively from a single pyrimidine residue that Watson-Crick basepairs with their respective ligands 25, 26 . Because the c-di-GMP riboswitch uses Watson-Crick pairing as only one of multiple strategies to recognize g I of its cognate ligand, and does not use Watson-Crick pairing to recognize g II , it is unlikely that two point mutations would result in high-affinity (K d ~1 nM) binding of c-di-AMP. Sequence alignments 6 suggest that some GEMM riboswitches have a uridine at the position that corresponds to C92, raising the possibility that they bind c-di-AMP. Although the ligand specificity of such RNAs will have to be determined experimentally, riboswitches have been shown to have considerable plasticity in their binding sites 28, 29 , and it is possible that a few mutations may allow evolution of a high-affinity c-di-AMP riboswitch from a c-di-GMP riboswitch.
Except for the glmS ribozyme-riboswitch 30, 31 , most riboswitches function by a mechanism in which stabilization of the aptamer domain (through the free energy of binding to their cognate ligand) results in sequestration of an RNA segment that would otherwise form part of an alternative structure: for instance, a rho-independent transcriptional terminator or a ribosome binding site [32] [33] [34] . Typically, this sequestered segment is part of P1 in the ligand-bound state. Analyses of the genomic contexts of c-di-GMP riboswitches 5 and in vivo reporter assays 6 suggest that such a mechanism is operative for at least some of these riboswitches. Our combined crystallographic, SAXS and biochemical analyses of the c-di-GMP riboswitch show that it undergoes a pronounced global structural rearrangement in response to ligand binding (Fig. 4) . This rearrangement probably involves folding of the J1a/b, J1b/2 and J2/1b regions (Fig. 1c) to form the second messenger-binding site, resulting in stabilization of helix P1a and, concomitantly, in stabilization of the side-by-side orientation of P1b and P2 through interhelical contacts and the ligand-induced structure of the three-helix junction itself. Comparison with other studies shows that such a conformational switch is not a general property of riboswitches. SAXS analysis of the glycine riboswitch 35 demonstrated that it undergoes pronounced Mg 2+ -and ligand-dependent conformational changes. In contrast, the lysine riboswitch 36,37 adopts essentially indistinguishable three-dimensional structures in the presence or absence of the amino acid and even in the absence of free Mg 2+ . Thus, it is possible that the large conformational switch we have uncovered is solely a consequence of the stabilization of the riboswitch aptamer domain structure by ligand binding. Alternatively, the conformational switch may have evolved to modulate the affinity 38, 39 of the riboswitch or its rate of folding 40, 41 so as to optimize its switching behavior in its physiological context.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Accession codes. Protein Data Bank: Coordinates and structure factor amplitudes for the V. cholerae tfoX c-di-GMP riboswitch in complex with c-di-GMP have been deposited with accession code 3IWN.
ONLINE METhODS
Reagent preparation and biochemical assays. We carried out transcription and purification of the 93-nucleotide (nt) crystallization RNA construct, preceded by a hammerhead ribozyme and followed by a VS ribozyme substrate stemloop, essentially as described 44, 45 . We prepared the 88-nt wild-type V. cholerae c-di-GMP riboswitch aptamer domain 6 similarly. Ref. 8 describes U1A-RBD (Y31H, Q36R) expression and purification. We purchased c-di-GMP and c-di-AMP from Axxora, LLC and used both without further purification.
For electrophoretic mobility shift assays (EMSA), we diluted RNA to 35 µM in a buffer comprising 5 mM Tris-HCl (pH 8.0), 3 mM MgCl 2 , 10 mM NaCl, and 100 mM KCl and small molecule (0 or 70 µM). After a 30-min incubation at 310 K, we resolved the samples on 10% polyacrylamide gels with 0.5× THE supplemented with 1 mM MgCl 2 as the running buffer. We stained the gels with toluidine blue. For nuclease probing, we prepared 32 P-labeled RNA in 50 mM Tris-HCl (pH 8.0), 30 mM NaCl, 30 mM KCl, appropriate final MgCl 2 concentration (1.8 mM, 2.4 mM, 3.0 mM) and either 0 or 70 µM c-di-GMP. We added 1 µl of nuclease (T1, 0.01 U µl −1 ; V1, 0.0025 U µl −1 ) to initiate structural probing. We performed reactions at 310 K for 5 min in a final volume of 5 µl, terminated them by addition of 5 µl gel loading buffer (Ambion) and loaded them immediately onto 10% polyacrylamide-8 M urea gels. We performed autoradiography by phosphorimaging. We performed nuclease mapping experiments in triplicate. We quantified cleavage bands that could be resolved as singular using ImageQuantTL software (GE Healthcare) and normalized them to a uniform band (nucleotide 17) across all lanes. We calculated protection ratios by dividing the intensity of the band in the absence of c-di-GMP by the intensity of the band in the presence of c-di-GMP. We report nucleotides with a protection ratio greater than 1.75 (T1 nuclease) and 1.25 (V1 nuclease) in Figure 4c ,d. Similarly, we report increased cleavage by nuclease V1 for ratios less than 0.8.
Crystallization and structure determination. We mixed RNA incubated as for EMSA, but at a final concentration of 250 µM (with 1 molar equivalent each of c-di-GMP and U1A-RBD and 1 mM spermine) with an equal volume of a reservoir solution comprising 30% (w/v) PEG 3,350, 300 mM ammonium acetate (pH 7.0), 100 mM Tris-HCl (pH 8.5). We obtained thin, plate-shaped crystals by vapor diffusion at 303 K over the course of 1 d. We flash froze a crystal directly from the mother liquor by plunging it into liquid nitrogen. We thawed and then annealed 46 this crystal in a solution comprising 35% (w/v) PEG 3,350, 320 mM ammonium acetate (pH 7.0), 100 mM Tris-HCl (pH 8.5) and 3 mM MgCl 2 , and flash froze it in the same manner as described above. We collected diffraction data by the oscillation method with 1-Å X-radiation at 100 K from one crystal at beamline 8.2.2 of the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory, and reduced the data with the HKL package 47 . High crystal mosaicity (~0.9°) and the relatively long c unit cell dimension limited the completeness and precision of the data.
We initiated structure determination by molecular replacement with PHASER 48 with four independent search models (two U1A-RBDs and their binding sites, and two 5-bp duplexes). In the first round, PHASER successfully placed two U1A-RBDs and their binding sites and one of the duplexes (translation function Z scores of 10.0, 16.8 and 10.1, respectively, and an overall loglikelihood gain of 446). We carried out iterative rounds of simulated annealing, energy minimization and tightly restrained individual B-factor refinement 42 (with a random 10% of the data reserved for cross-validation), interspersed with further rounds of molecular replacement to achieve complete tracing 49 of both RNA-protein complexes in the asymmetric unit. This model had a free-R factor of 31.4%, and a residual Fourier synthesis calculated with phases derived from it revealed clear electron density for the two bound c-di-GMP molecules (Fig. 1a) . We manually placed the second messengers into the residual electron density and carried out further refinement, which smoothly reduced the free-R factor to 29.2%. We used an anisotropic B-factor correction and an automatic solvent mask throughout. We did not use noncrystallographic symmetry restraints. We chose B-factor restraints to minimize the free-R factor (the r.m.s. deviation of B-factors of covalently bonded atoms is 0.49 Å 2 ). The current model has a cross-validated σA coordinate precision of 0.54 Å. 95.8% of residues of the U1A-RBDs lie in the most favored and additionally allowed regions of the Ramachandran plot 50 . There are no residues with disallowed backbone conformations. We prepared crystal structure figures with RIBBONS 51 using the coordinates of RNA chain A.
Small-angle X-ray scattering. We prepared SAXS samples similarly to the nuclease probing samples, with slight modifications (20 µM RNA, 100 µl final volume). We also prepared identical buffers (Supplementary Methods). We collected data under continuous flow at 310 K at the BioCAT beamline of the Advanced Photon Source (APS), Argonne National Laboratory. We analyzed buffer-subtracted data using IGOR (Wavemetrics, Inc.). We used Guinier analysis in the range q*R g ~1 to calculate the radii of gyration. We averaged multiple DAMMIN 52 reconstructions using DAMAVER 53 . We converted the filtered, averaged reconstructions to electron density map using SITUS 54 . We display these molecular envelope reconstructions with CHIMERA 55 . We computed the scattering profile of molecular models using CRYSOL 56 .
